Ray A. James - Concepedia

Author

Ray A. James

Also Known As

R. A. JAMES, Ray A. James, Ray James

Publications

332

Citations

H-Index

Concepts

All Affiliations

Ray A. James is an author at Ligand Pharmaceuticals (United States) specializing in drug discovery, medicine, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	270
2	Biochemistry	4	4	319
3	Natural Sciences	3	3	254
4	Chemical Biology	1	1	174
5	Chemistry	1	1	62

Ray A. James

Publications

332

Citations

H-Index

Page 1

	Year	Citations
Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases Kamil Paruch, Michael P. Dwyer, Carmen Álvarez, ACS Medicinal Chemistry Letters Drug TargetPathologyChemical BiologyPharmaceutical ChemistryTumor Biology	2010	174
Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2 Kamil Paruch, Michael P. Dwyer, Carmen Álvarez, Bioorganic & Medicinal Chemistry Letters Cyclin-dependent Kinase 2BiochemistryMedicineRational Drug DesignPharmacotherapy	2007	65
Stereoselective synthesis of 2-deoxy-β-glycosides from glycal precursors. 2. Stereochemistry of glycosidation reactions of 2-thiophenyl- and 2-selenophenyl-α-d-gluco-pyranosyl donors William Roush, David P. Sebesta, Ray A. James Tetrahedron BiochemistryNatural SciencesGlycobiologyOrganic ChemistryGlycal Precursors	1997	62
2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors Andrew G. Cole, Adolph C. Bohnstedt, Vidyadhar M. Paradkar, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	2009	18
Novel pyrrolidine heterocycles as CCR1 antagonists J. Robert Merritt, Ray A. James, Vidyadhar M. Paradkar, Bioorganic & Medicinal Chemistry Letters HeterocyclicMedicineNovel Pyrrolidine HeterocyclesHeterocycle ChemistryPharmacology	2010	13

Page 1